Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000919947 | SCV001065302 | likely benign | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV001195476 | SCV001365853 | likely benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Glu4133Glu in Exon 63 of USH2A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 0.2% (7/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs150406015). |
Genome- |
RCV003454953 | SCV004182004 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001274934 | SCV004182005 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001274934 | SCV001459516 | uncertain significance | Usher syndrome type 2A | 2020-02-13 | no assertion criteria provided | clinical testing |